Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma
Clinical trial NCT02107937 · COMPLETED
Trial details
- NCT number
- NCT02107937
- Sponsor
- SOTIO a.s.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2020-11-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.